文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

Rumble R H, Brooks P M, Roberts M S

Br J Clin Pharmacol. 1980 Jan;9(1):41-5. doi: 10.1111/j.1365-2125.1980.tb04794.x.

The effects of chronic administration of aspirin in therapeutic doses (3.9 g/day) on plasma and salivary salicylate levels were studied in eight subjects. 2. The urinary excretion profile for free salicylic acid and metabolites of salicylate were examined. 3. Plasma and salivary salicylate levels declined significantly after peak levels were achieved between days 3 and 10. 4. The decline in plasma and salivary salicylate levels may be due to an induction of a metabolic pathway such as salicylurate formation (Furst, Gupta & Paulus, 1977). Only the mean fraction of salicylate excreted as salicylurate appears to increase with time during the present study, although the change was not significant statistically. 5. The decline in plasma and salivary salicylate levels during chronic therapy may lead to an apparent 'tolerance' of some rheumatoid patients to aspirin.

研究了八名受试者长期服用治疗剂量的阿司匹林（3.9克/天）对血浆和唾液中水杨酸盐水平的影响。2. 检测了游离水杨酸和水杨酸盐代谢产物的尿排泄情况。3. 在第3天至第10天达到峰值水平后，血浆和唾液中的水杨酸盐水平显著下降。4. 血浆和唾液中水杨酸盐水平的下降可能是由于诱导了一种代谢途径，如水杨尿酸的形成（Furst、Gupta和Paulus，1977年）。在本研究中，只有作为水杨尿酸排泄的水杨酸盐平均比例似乎随时间增加，尽管这一变化在统计学上并不显著。5. 长期治疗期间血浆和唾液中水杨酸盐水平的下降可能导致一些类风湿性关节炎患者对阿司匹林产生明显的“耐受性”。

Rumble R H, Brooks P M, Roberts M S

Br J Clin Pharmacol. 1980 Jan;9(1):41-5. doi: 10.1111/j.1365-2125.1980.tb04794.x.

The effects of chronic administration of aspirin in therapeutic doses (3.9 g/day) on plasma and salivary salicylate levels were studied in eight subjects. 2. The urinary excretion profile for free salicylic acid and metabolites of salicylate were examined. 3. Plasma and salivary salicylate levels declined significantly after peak levels were achieved between days 3 and 10. 4. The decline in plasma and salivary salicylate levels may be due to an induction of a metabolic pathway such as salicylurate formation (Furst, Gupta & Paulus, 1977). Only the mean fraction of salicylate excreted as salicylurate appears to increase with time during the present study, although the change was not significant statistically. 5. The decline in plasma and salivary salicylate levels during chronic therapy may lead to an apparent 'tolerance' of some rheumatoid patients to aspirin.

研究了八名受试者长期服用治疗剂量的阿司匹林（3.9克/天）对血浆和唾液中水杨酸盐水平的影响。2. 检测了游离水杨酸和水杨酸盐代谢产物的尿排泄情况。3. 在第3天至第10天达到峰值水平后，血浆和唾液中的水杨酸盐水平显著下降。4. 血浆和唾液中水杨酸盐水平的下降可能是由于诱导了一种代谢途径，如水杨尿酸的形成（Furst、Gupta和Paulus，1977年）。在本研究中，只有作为水杨尿酸排泄的水杨酸盐平均比例似乎随时间增加，尽管这一变化在统计学上并不显著。5. 长期治疗期间血浆和唾液中水杨酸盐水平的下降可能导致一些类风湿性关节炎患者对阿司匹林产生明显的“耐受性”。